| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K33514849 | CTRPv2 | pan-cancer | AAC | 0.021 | 0.9 |
| mRNA | KU-55933 | GDSC1000 | pan-cancer | AAC | -0.0067 | 0.9 |
| mRNA | BRD-K16147474 | CTRPv2 | pan-cancer | AAC | 0.0065 | 0.9 |
| mRNA | ABT-888 | CTRPv2 | pan-cancer | AAC | -0.006 | 0.9 |
| mRNA | ETP-46464 | CTRPv2 | pan-cancer | AAC | 0.0068 | 0.9 |
| mRNA | CAY10594 | CTRPv2 | pan-cancer | AAC | -0.006 | 0.9 |
| mRNA | CIL55 | CTRPv2 | pan-cancer | AAC | 0.0094 | 0.9 |
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | -0.0055 | 0.9 |
| mRNA | KU-60019 | CTRPv2 | pan-cancer | AAC | 0.0052 | 0.9 |
| mRNA | importazole | CTRPv2 | pan-cancer | AAC | -0.0058 | 0.9 |